Treatment of the primary hyperoxalurias: A new chapter

D. Milliner

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.

Original languageEnglish (US)
Pages (from-to)1198-1200
Number of pages3
JournalKidney International
Volume70
Issue number7
DOIs
StatePublished - Oct 9 2006

Fingerprint

Oxalobacter formigenes
Primary Hyperoxaluria
Oxalates
Molecular Biology
Bacteria
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

Treatment of the primary hyperoxalurias : A new chapter. / Milliner, D.

In: Kidney International, Vol. 70, No. 7, 09.10.2006, p. 1198-1200.

Research output: Contribution to journalArticle

Milliner, D. / Treatment of the primary hyperoxalurias : A new chapter. In: Kidney International. 2006 ; Vol. 70, No. 7. pp. 1198-1200.
@article{965d9aea9f664f7d9ca9b6a243cbc6e6,
title = "Treatment of the primary hyperoxalurias: A new chapter",
abstract = "Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.",
author = "D. Milliner",
year = "2006",
month = "10",
day = "9",
doi = "10.1038/sj.ki.5001821",
language = "English (US)",
volume = "70",
pages = "1198--1200",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Treatment of the primary hyperoxalurias

T2 - A new chapter

AU - Milliner, D.

PY - 2006/10/9

Y1 - 2006/10/9

N2 - Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.

AB - Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.

UR - http://www.scopus.com/inward/record.url?scp=33748923652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748923652&partnerID=8YFLogxK

U2 - 10.1038/sj.ki.5001821

DO - 10.1038/sj.ki.5001821

M3 - Article

C2 - 16988727

AN - SCOPUS:33748923652

VL - 70

SP - 1198

EP - 1200

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 7

ER -